| Dr Falan Nichole Mcknight, MD | |
|
8613 Ms Highway 12, Ackerman, MS 39735-8917 | |
| (662) 285-4400 | |
| Not Available |
| Full Name | Dr Falan Nichole Mcknight |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 5 Years |
| Location | 8613 Ms Highway 12, Ackerman, Mississippi |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073173514 | NPI | - | NPPES |
| 000500036 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 28737 (Mississippi) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sta Home Health And Hospice | Carthage, MS | Home health agency |
| Kindred At Home | Columbus, MS | Home health agency |
| Kindred At Home | Bruce, MS | Home health agency |
| Gentiva Hospice | Starkville, MS | Hospice |
| Quality Hospice Care, Inc | Philadelphia, MS | Hospice |
| Choctaw Regional Medical Center | Ackerman, MS | Hospital |
| Winston Medical Center & Swingbed | Louisville, MS | Hospital |
| Och Regional Medical Center | Starkville, MS | Hospital |
| Winston County Nursing Home | Louisville, MS | Nursing home |
| Louisville Healthcare Llc | Louisville, MS | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Choctaw Regional Medical Center | 2567682206 | 26 |
News Archive
Photocure, the world leader in photodynamic technology today announced the commercial launch of Allumera in the US, the first Photodynamic Cosmetic specifically formulated to improve the overall appearance of skin, reduce outward signs of aging and minimize the appearance of pores with minimal downtime and results that last.
Teva Pharmaceutical Industries Ltd., and Labrys Biologics, Inc., a privately-held development stage biotechnology company focused on treatments for chronic migraine and episodic migraine, today announced that Teva has entered into a definitive agreement to acquire Labrys, broadening Teva's array of biotechnology assets and capabilities.
Investigators at The Feinstein Institute for Medical Research have discovered that brain scans can be used to predict patients' response to antipsychotic drug treatment. The findings are published online in the latest issue of The American Journal of Psychiatry.
With more than 1.8 million children in the U.S. being treated annually with drugs for attention deficit hyperactivity disorder, the possibility that such drugs could damage their hearts has been a significant cause of concern for parents and physicians alike.
Investigators from Memorial Sloan Kettering Cancer Center have reported more encouraging news about one of the most exciting methods of cancer treatment today. The largest clinical study ever conducted to date of patients with advanced leukemia found that 88 percent achieved complete remissions after being treated with genetically modified versions of their own immune cells.
› Verified 2 days ago
| Entity Name | Choctaw Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235547878 PECOS PAC ID: 2567682206 Enrollment ID: O20141215002502 |
News Archive
Photocure, the world leader in photodynamic technology today announced the commercial launch of Allumera in the US, the first Photodynamic Cosmetic specifically formulated to improve the overall appearance of skin, reduce outward signs of aging and minimize the appearance of pores with minimal downtime and results that last.
Teva Pharmaceutical Industries Ltd., and Labrys Biologics, Inc., a privately-held development stage biotechnology company focused on treatments for chronic migraine and episodic migraine, today announced that Teva has entered into a definitive agreement to acquire Labrys, broadening Teva's array of biotechnology assets and capabilities.
Investigators at The Feinstein Institute for Medical Research have discovered that brain scans can be used to predict patients' response to antipsychotic drug treatment. The findings are published online in the latest issue of The American Journal of Psychiatry.
With more than 1.8 million children in the U.S. being treated annually with drugs for attention deficit hyperactivity disorder, the possibility that such drugs could damage their hearts has been a significant cause of concern for parents and physicians alike.
Investigators from Memorial Sloan Kettering Cancer Center have reported more encouraging news about one of the most exciting methods of cancer treatment today. The largest clinical study ever conducted to date of patients with advanced leukemia found that 88 percent achieved complete remissions after being treated with genetically modified versions of their own immune cells.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Falan Nichole Mcknight, MD 1665 S Green St, Tupelo, MS 38804-6556 Ph: (662) 377-2189 | Dr Falan Nichole Mcknight, MD 8613 Ms Highway 12, Ackerman, MS 39735-8917 Ph: (662) 285-4400 |
News Archive
Photocure, the world leader in photodynamic technology today announced the commercial launch of Allumera in the US, the first Photodynamic Cosmetic specifically formulated to improve the overall appearance of skin, reduce outward signs of aging and minimize the appearance of pores with minimal downtime and results that last.
Teva Pharmaceutical Industries Ltd., and Labrys Biologics, Inc., a privately-held development stage biotechnology company focused on treatments for chronic migraine and episodic migraine, today announced that Teva has entered into a definitive agreement to acquire Labrys, broadening Teva's array of biotechnology assets and capabilities.
Investigators at The Feinstein Institute for Medical Research have discovered that brain scans can be used to predict patients' response to antipsychotic drug treatment. The findings are published online in the latest issue of The American Journal of Psychiatry.
With more than 1.8 million children in the U.S. being treated annually with drugs for attention deficit hyperactivity disorder, the possibility that such drugs could damage their hearts has been a significant cause of concern for parents and physicians alike.
Investigators from Memorial Sloan Kettering Cancer Center have reported more encouraging news about one of the most exciting methods of cancer treatment today. The largest clinical study ever conducted to date of patients with advanced leukemia found that 88 percent achieved complete remissions after being treated with genetically modified versions of their own immune cells.
› Verified 2 days ago
Mr. Harmon Sidney Prosser, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 64 N Louisville St, Ackerman, MS 39735 Phone: 662-285-9050 Fax: 662-285-9056 | |
Dr. Shunda Lynette Garner, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8613 Ms Highway 12, Ackerman, MS 39735 Phone: 662-285-4400 | |
Prentiss Parsons, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 356 W Cherry St, Ackerman, MS 39735 Phone: 662-285-3243 Fax: 662-285-3613 |